The SPS CE Lunchtime Mini Course, chaired by Mark Deurinck, Novartis, is one of the highlights of the SPS Annual Meeting. In this course, three case studies will be presented by renowned safety pharmacology experts. Each case study will consist of a 15-minute presentation followed by a 5-min Q&A.
The Continuing Education (CE) courses provide excellent lectures to participants at Annual Meetings. The SPS PM 3 Continuing Education Course, chaired by Scott Mittelstadt, PhD, Abbott Laboratories and Mark A. Osinski, PhD, Covance Laboratories Inc. is a featured course for 2012.
As SPS continues to increase the services available to the membership, we are migrating the SPSpeak Forum to the SPShare SPeak blog. This technology change will facilitate multi-communications opportunities.